Drug Trial Radar · NCT06952517
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
Last checked: Nov 20, 2026Latest source record: May 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Mar 14, 2025
Primary completion
Sep 1, 2025
Study completion Sep 30, 2025
Sponsor
- Lead sponsor
- Narrows Institute for Biomedical ResearchAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sun Pharmaceutical Industries Limited
- First posted
- May 1, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To demonstrate the efficacy of Clascoterone cream 1% in reducing the size of sebaceous glands in study participants with acneiform rosacea.
Conditions
- Papular-pustular Rosacea
- Papulopustular Rosacea (PPR)
- Papulopustular Rosacea
Interventions
Clascoterone Cream 1%Drug
Clascoterone 1% cream
Primary outcomes
What the sponsor says the trial is designed to measure.
- Biopsy proven reduction in size of sebaceous glands at the end of 12 weeks of treatment compared to the baseline.Time frame: From enrollment to end of treatment at 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
New York Harbor VA Brooklyn Campus
Brooklyn, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.